CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 2030978888 support@capital.com

Handel ADMA Biologics, Inc. - ADMA CFD

2.9809
2.92%
0.0282
Lav: 2.9809
Høj: 3.0806
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.0282
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.024068%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
0.001846%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Nøglestatistikker
Tidligere luk* 3.0706
Åben* 3.0207
1-Års Ændring* 97.43%
Dagens Spænd* 2.9809 - 3.0806
52-Ugers Spænd 1.43-3.98
Gennemsnitlig Volumen (10 dage) 3.13M
Gennemsnitlig Volumen (3 måneder) 49.74M
Market Cap 675.04M
P/E-forhold -100.00K
Udestående aktier 217.76M
Omsætning 130.48M
EPS -0.37
Dividend (Udbytte %) N/A
Beta 0.92
Næste indtjeningsopgørelse Mar 23, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Mar 22, 2023 2.9809 -0.0697 -2.28% 3.0506 3.0905 2.9809
Mar 21, 2023 3.0706 0.0300 0.99% 3.0406 3.1703 3.0406
Mar 20, 2023 3.0507 -0.0299 -0.97% 3.0806 3.1005 2.9310
Mar 17, 2023 3.0606 -0.0298 -0.96% 3.0904 3.1204 3.0207
Mar 16, 2023 3.1105 0.0300 0.97% 3.0805 3.1703 3.0506
Mar 15, 2023 3.1105 0.0001 0.00% 3.1104 3.1902 3.0806
Mar 14, 2023 3.2002 -0.0099 -0.31% 3.2101 3.2600 3.1603
Mar 13, 2023 3.1803 0.1696 5.63% 3.0107 3.2201 3.0008
Mar 10, 2023 3.0806 -0.1594 -4.92% 3.2400 3.2600 3.0307
Mar 9, 2023 3.2600 -0.1496 -4.39% 3.4096 3.4395 3.2102
Mar 8, 2023 3.3896 0.0100 0.30% 3.3796 3.4495 3.3497
Mar 7, 2023 3.3797 0.0200 0.60% 3.3597 3.4495 3.2998
Mar 6, 2023 3.3398 -0.0697 -2.04% 3.4095 3.4295 3.2999
Mar 3, 2023 3.3996 -0.0897 -2.57% 3.4893 3.4893 3.3697
Mar 2, 2023 3.4395 -0.0698 -1.99% 3.5093 3.5392 3.4395
Mar 1, 2023 3.5292 -0.0099 -0.28% 3.5391 3.6489 3.5292
Feb 28, 2023 3.5392 0.0798 2.31% 3.4594 3.5890 3.4594
Feb 27, 2023 3.4694 0.0599 1.76% 3.4095 3.5192 3.3996
Feb 24, 2023 3.4096 0.0101 0.30% 3.3995 3.4694 3.3995
Feb 23, 2023 3.4893 -0.0100 -0.29% 3.4993 3.5192 3.4594

ADMA Biologics, Inc. Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Total omsætning 80.9426 42.2198 29.3491 16.9853 22.7606
Omsætning 80.9426 42.2198 29.3491 16.9853 22.7606
Kost af omsætning, Total 79.7693 61.2914 39.5042 42.1946 29.1643
Bruttofortjeneste 1.17329 -19.0716 -10.1552 -25.2094 -6.40376
Totale Driftsudgifter 139.316 106.143 80.7359 77.2742 63.2808
Salgs/Generelle/Admin. Udgifter, Total 55.1856 39.2209 28.0804 30.3085 24.5966
Forskning & Udvikling 3.64606 5.90701 2.34385 3.92612 6.22959
Usædvanlig Udgift (Indkomst) 0 -0.9918 9.9625 0 2.05561
Driftsindtægter -58.3737 -63.9231 -51.3868 -60.2889 -40.5202
Renteindkomst (Udgift), Netto Ikke-Drift -13.0223 -11.6969 -8.19259 -5.32738 -3.22862
Andre, Netto -0.25158 -0.12853 -0.22732 -0.12712 -0.01014
Netto Indkomst Før Skat -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Netto Indkomst Efter Skat -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Netto Indkomst Før Ekstra Ting -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Netto Indkomst -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Fortyndet Netto Indkomst -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Fortyndet Vægtet Gennemsnit Aktier 139.579 86.1451 54.3481 45.1889 22.896
Fortyndet EPS Uden Ekstraordinære Ting -0.51331 -0.87931 -0.88833 -1.45486 -1.9112
Fortyndet Normaliseret EPS -0.51331 -0.89083 -0.91713 -1.45486 -1.82142
Depreciation / Amortization 0.71535 0.71535 0.84494 0.84494 1.23467
Totale Ekstraordinære Ting 0
Gain (Loss) on Sale of Assets 0 11.5274
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total omsætning 29.1031 26.3829 20.6805 17.8306 16.0486
Omsætning 29.1031 26.3829 20.6805 17.8306 16.0486
Kost af omsætning, Total 25.441 22.8714 20.2952 18.8326 17.7701
Bruttofortjeneste 3.66204 3.51149 0.38534 -1.00203 -1.7215
Totale Driftsudgifter 50.5881 39.5741 35.1176 33.4118 31.2129
Salgs/Generelle/Admin. Udgifter, Total 17.6742 15.7948 13.873 13.2415 12.2763
Forskning & Udvikling 0.62411 0.72899 0.77056 1.15887 0.98765
Depreciation / Amortization 0.17884 0.17884 0.17884 0.17884 0.17884
Driftsindtægter -21.485 -13.1912 -14.4371 -15.5812 -15.1643
Renteindkomst (Udgift), Netto Ikke-Drift -3.35597 -3.31343 -3.29442 -3.24075 -3.17369
Andre, Netto -0.16688 -0.1448 0.01855 -0.08332 -0.042
Netto Indkomst Før Skat -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Netto Indkomst Efter Skat -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Netto Indkomst Før Ekstra Ting -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Netto Indkomst -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Fortyndet Netto Indkomst -25.0079 -16.6494 -17.7129 -18.9053 -18.3799
Fortyndet Vægtet Gennemsnit Aktier 195.872 181.267 133.77 127.416 115.662
Fortyndet EPS Uden Ekstraordinære Ting -0.12767 -0.09185 -0.13241 -0.14837 -0.15891
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS -0.09362 -0.09185 -0.13241 -0.14837 -0.15891
Usædvanlig Udgift (Indkomst) 6.66994 0
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Totale Nuværende Aktiver 208.729 153.741 85.8204 44.5296 62.3416
Likvider og Kortsigtede Investeringer 51.0891 55.9212 26.7521 22.7549 43.1076
Likvider & Lignende 51.0891 55.9212 26.7521 22.7549 43.1076
Kortsigtede Investeringer
Totale Tilgodehavender, Netto 28.5769 13.2373 3.46992 1.39244 3.88015
Accounts Receivable - Trade, Net 28.5769 13.2373 3.46992 1.39244 3.88015
Total Inventory 124.724 81.5356 53.0647 18.6162 12.6282
Prepaid Expenses 4.33925 3.04647 2.53359 1.76616 1.22565
Total Assets 276.253 207.673 127.091 88.8765 108.019
Property/Plant/Equipment, Total - Net 58.1977 45.8523 33.1413 30.1157 30.4669
Property/Plant/Equipment, Total - Gross 71.4696 54.7162 38.8663 33.5368 31.7528
Accumulated Depreciation, Total -13.2718 -8.86394 -5.72496 -3.42103 -1.28592
Other Long Term Assets, Total 4.0674 2.10698 1.44004 6.69725 6.83155
Total Current Liabilities 30.3783 19.9474 14.0279 9.62505 9.44018
Accounts Payable 12.4294 11.0737 9.17459 5.90039 5.92087
Accrued Expenses 16.7941 8.73083 4.71047 3.58182 3.37648
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total 1.15482 0.14283 0.14283 0.14283 0.14283
Total Liabilities 135.08 119.424 100.898 69.1061 67.6861
Total Long Term Debt 94.8662 92.9689 83.1992 44.075 42.9709
Long Term Debt 94.8662 92.9689 83.1992 44.075 42.9709
Other Liabilities, Total 9.8356 6.50774 3.67047 15.406 15.275
Total Equity 141.173 88.2494 26.1931 19.7704 40.3328
Common Stock 0.01958 0.01049 0.00593 0.00464 0.00453
Additional Paid-In Capital 553.266 428.704 290.904 236.203 191.022
Retained Earnings (Accumulated Deficit) -412.113 -340.465 -264.717 -216.437 -150.694
Total Liabilities & Shareholders’ Equity 276.253 207.673 127.091 88.8765 108.019
Total Common Shares Outstanding 195.814 104.903 59.3184 46.3531 36.7255
Other Current Assets, Total 0 1.5
Goodwill, Net 3.52951 3.52951 3.52951 3.52951 3.52951
Intangibles, Net 1.72877 2.44412 3.15947 4.00441 4.84935
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Totale Nuværende Aktiver 239.8 208.729 174.785 171.355 177.277
Likvider og Kortsigtede Investeringer 69.505 51.0891 34.4106 42.409 61.9657
Likvider & Lignende 69.505 51.0891 34.4106 42.409 61.9657
Totale Tilgodehavender, Netto 25.6296 28.5769 20.3926 23.5446 15.362
Accounts Receivable - Trade, Net 25.6296 28.5769 20.3926 23.5446 15.362
Total Inventory 139.146 124.724 114.123 99.6997 94.1462
Prepaid Expenses 5.5193 4.33925 5.85905 5.70186 5.80261
Total Assets 308.033 276.253 238.64 232.814 235.667
Property/Plant/Equipment, Total - Net 60.3271 58.1977 55.0847 53.316 50.3729
Property/Plant/Equipment, Total - Gross 75.0076 71.4696 67.2809 64.2715 60.2769
Accumulated Depreciation, Total -14.6804 -13.2718 -12.1962 -10.9555 -9.90401
Goodwill, Net 3.52951 3.52951 3.52951 3.52951 3.52951
Intangibles, Net 1.54993 1.72877 1.90761 2.08645 2.26528
Other Long Term Assets, Total 2.82575 4.0674 3.33351 2.52666 2.22278
Total Current Liabilities 31.5665 30.3783 32.3372 18.1864 21.2057
Accounts Payable 14.1151 12.4294 17.2828 6.16747 12.1529
Accrued Expenses 14.2198 16.7941 13.0301 10.7303 8.14151
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 3.23159 1.15482 2.02432 1.28866 0.91137
Total Liabilities 181.099 135.08 135.86 121.22 123.163
Total Long Term Debt 138.423 94.8662 94.363 93.877 93.4127
Long Term Debt 138.423 94.8662 94.363 93.877 93.4127
Other Liabilities, Total 11.1099 9.8356 9.15999 9.15685 8.54454
Total Equity 126.933 141.173 102.78 111.594 112.504
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.01964 0.01958 0.01383 0.01319 0.0123
Additional Paid-In Capital 564.034 553.266 498.23 489.331 471.337
Retained Earnings (Accumulated Deficit) -437.121 -412.113 -395.463 -377.75 -358.845
Total Liabilities & Shareholders’ Equity 308.033 276.253 238.64 232.814 235.667
Total Common Shares Outstanding 196.348 195.814 138.314 131.872 123.045
  • Årlig
  • Pr kvartal
2021 2020 2019 2018 2017
Netto indkomst/Startlinje -71.6476 -75.7486 -48.2793 -65.7434 -43.759
Likvider Fra Driftsaktiviteter -112.369 -102.003 -76.1935 -62.6787 -37.2718
Likvider Fra Driftsaktiviteter 5.4955 3.94229 3.25815 3.4464 2.6923
Ikke-Likvide Ting 5.46355 3.58462 2.33044 3.30681 4.07714
Likvid Rente Betalt 11.1595 10.2676 8.11223 4.39997 2.29359
Ændringer i Driftskapital -51.6804 -33.7813 -33.5028 -3.68844 -0.28224
Likvider fra Investeringsaktiviteter -13.5113 -12.7247 -3.81184 -2.0956 15.2139
Kapitaludgifter -13.5113 -12.7267 -3.81184 -2.0956 -2.67633
Andre Investerings-Cash-Flow-Ting, Total 0 0.002 0 17.8902
Likvider fra Financieringsaktiviteter 121.048 143.897 80.0026 42.9216 60.7506
Financiering af Cash-Flow-Ting -0.0616 -0.83 -10.9395 0 -3.44017
Udstedelse (Pensionering) af Aktier, Netto 121.144 131.209 48.4721 42.9578 39.2074
Udstedelse (Pensionering) af Gæld, Netto -0.0343 13.5179 42.47 -0.03628 24.9834
Netto Ændring i Likviditet -4.83203 29.169 -0.00272 -21.8527 38.6927
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -25.0079 -71.6476 -54.9982 -37.2852 -18.3799
Cash From Operating Activities -26.0134 -112.369 -78.9037 -65.4914 -33.2291
Cash From Operating Activities 1.59022 5.4955 3.97779 2.55562 1.22963
Non-Cash Items 8.86246 5.46355 3.64236 2.50146 1.19026
Cash Interest Paid 2.52599 11.1595 8.34697 5.53428 2.75196
Changes in Working Capital -11.4582 -51.6804 -31.5257 -33.2632 -17.2691
Cash From Investing Activities -2.84209 -13.5113 -9.8354 -7.04674 -2.57116
Capital Expenditures -2.84209 -13.5113 -9.8354 -7.04674 -2.57116
Other Investing Cash Flow Items, Total 0 0 0 0
Cash From Financing Activities 47.2713 121.048 67.2286 59.0259 41.8448
Financing Cash Flow Items -4.46973 -0.0616 -0.0616 -0.05931 -0.05931
Issuance (Retirement) of Stock, Net 0 121.144 67.3157 59.1021 41.9125
Issuance (Retirement) of Debt, Net 51.7411 -0.0343 -0.02551 -0.01686 -0.00836
Net Change in Cash 18.4158 -4.83203 -21.5106 -13.5122 6.04456
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.1941 13488055 1946140 2022-12-31 LOW
Perceptive Advisors LLC Private Equity 5.465 11900255 966868 2022-12-31 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.0548 11007209 1583787 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.9762 10835875 1545176 2022-12-31 LOW
NWQ Investment Management Company, LLC Investment Advisor/Hedge Fund 4.8736 10612600 3727960 2021-12-31 LOW
D. E. Shaw & Co., L.P. Hedge Fund 3.9073 8508409 2664613 2022-12-31 MED
Stonepine Capital Management, LLC Investment Advisor/Hedge Fund 3.1871 6940000 1940000 2022-12-31 MED
Magnetar Capital Partners LP Investment Advisor/Hedge Fund 2.8414 6187316 1815908 2022-12-31 HIGH
AWM Investment Company, Inc. Investment Advisor/Hedge Fund 2.7623 6015000 1000000 2022-12-31 LOW
Millennium Management LLC Hedge Fund 2.4324 5296781 3569778 2022-12-31 HIGH
Nuveen Asset Management, LLC Investment Advisor/Hedge Fund 1.8845 4103514 -883582 2022-12-31 LOW
Velan Capital Investment Management LP Investment Advisor/Hedge Fund 1.8369 4000000 -1269155 2022-12-31 MED
Invesco Advisers, Inc. Investment Advisor 1.7886 3894678 813693 2022-12-31 LOW
Aisling Capital, LLC Private Equity 1.6604 3615671 0 2022-04-15
Nuveen LLC Pension Fund 1.5839 3448993 -267644 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5553 3386852 100723 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 1.364 2970124 1530127 2022-12-31 HIGH
Altium Capital Management LP Investment Advisor/Hedge Fund 1.318 2870000 -13710 2022-12-31 HIGH
Morgan Stanley & Co. LLC Research Firm 1.2959 2821903 558990 2022-12-31 MED
Caligan Partners, LP Hedge Fund 1.2289 2676093 -8217144 2022-12-31 MED

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group

500K+

Handlende

92K+

Månedlkige, aktive klienter

$53M+

Månedlig investeringsvolumen

$30M+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

ADMA Biologics, Inc. Company profile

Om ADMA Biologics, Inc.

ADMA Biologics, Inc. er en biofarmaceutisk virksomhed. Virksomheden udvikler, fremstiller og markedsfører specialiserede plasmabaserede biologiske lægemidler til behandling og forebyggelse af smitsomme sygdomme. Virksomheden beskæftiger sig med udvikling og kommercialisering af human plasma og plasmaafledte terapeutika. Virksomhedens patienter omfatter immunsvækkede personer, der lider af en underliggende immundefekt sygdom og er immunsupprimeret af medicinske årsager. Virksomhedens produktkandidater omfatter BIVIGAM, et intravenøst immunglobulinprodukt (IVIG) til behandling af primær humoral immundefekt (PI), ASCENIV, et IVIG-produkt til behandling af PI, og Nabi-HB, der er indiceret til behandling af akut eksponering for blod indeholdende hepatitis B-overfladeantigen (HBsAg). Dets datterselskab ADMA BioCenters driver faciliteter til indsamling af kildeplasma i USA. Dets segment Plasma Collection Centers leverer en del af sit blodplasma til fremstilling af sine produktkandidater.

Industry: Biopharmaceuticals

C/O Adma Biologics, Inc.
465 State Route 17
RAMSEY
NEW JERSEY 07446
US

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

XRP/USD

0.42 Price
-0.880% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00381

BTC/USD

27,371.35 Price
-0.020% 1D Chg, %
Long position, gebyr natten over -0.0616%
Short position, gebyr natten over 0.0137%
Gebyr natten over, tid 21:00 (UTC)
Spænd 60.00

Oil - Crude

70.22 Price
+0.370% 1D Chg, %
Long position, gebyr natten over -0.0170%
Short position, gebyr natten over -0.0050%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

Gold

1,978.12 Price
+0.350% 1D Chg, %
Long position, gebyr natten over -0.0086%
Short position, gebyr natten over 0.0004%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel